Company news

PolyNovo Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Chairman, Managing Director & SVP of Sales US - AGM address

November 13, 2020

USA FDA approves Pivotal Trial IDE

November 12, 2020

Taiwan FDA Approval for PolyNovo

October 27, 2020

Appointment of distributor for Finland

September 22, 2020

FY20 Results Presentation

August 26, 2020

Appendix 4E and FY20 Annual Report

August 26, 2020

BARDA funding for Pivotal Trial

July 14, 2020

Trading Update

July 9, 2020

Pivotal Trial Protocol - Update

July 9, 2020

Appt Brennan as MD PNV

April 23, 2020

Feasibility Study Results Summary

April 21, 2020

Debt Finance Facility

April 6, 2020

Letter to Shareholders

March 10, 2020

Half Year Results 2020 Presentation

February 25, 2020

CEO interviewed by Alan Kohler

February 4, 2020

UK/Ireland Progress Update

January 28, 2020

Europe Progress Update

January 21, 2020

Two Million Dollar Month

January 7, 2020

BTM CE mark approval

December 13, 2019

AGM 2019 Chairman, CEO & SVP Sales Address

November 15, 2019

S&P DJI Announces September 2019 Quarterly Rebalance

September 5, 2019

Annual Report Brokers Presentation

August 22, 2019

Annual Report FY19 and 4E

August 21, 2019

Singapore Regulatory Approval

August 8, 2019

Progress Report

May 31, 2019

Million Dollar Month

May 2, 2019

US Dept of Defence & access to other Federal contracts

May 1, 2019

Half Yearly Report and Accounts

February 21, 2019

PolyNovo Purchases additional production facility

January 18, 2019

Malaysia Regulatory Approval

January 17, 2019

H1 Sales FY19 PolyNovo

January 7, 2019

PolyNovo Sales FY19 YTD Market Update

November 28, 2018

AGM Chairman and CEO Address to Shareholders

November 16, 2018

NovoSorb BTM aaproved for sale in India

November 1, 2018

S&P DJI Announces September 2018 Quarterly Rebalance

September 6, 2018

Annual Report to Shareholders and Appendix 4E

August 16, 2018

Final Patient enrolled in BARDA Feasibility Burn Trial

August 2, 2018

NovoSorb BTM approved for sale in Saudi Arabia

July 26, 2018

Final patient enrolled in CE Mark Burn Trial

May 22, 2018

PolyNovo Announces Breast Device Development Program

April 3, 2018

Results announcement, App 4D and Half-Year Financial Report

February 15, 2018

PolyNovo Announces Breast Device Development Agreement

January 17, 2018

PolyNovo signs MOU for global breast partnership

October 15, 2017

New Sales and Repeat Orders in the US

October 11, 2017

PolyNovos Israel Market Entry

October 4, 2017

Placement and Share Purchase Plan

September 24, 2017

Further US Sales for NovoSorb BTM

September 14, 2017

First US Sales of BTM Novosorb

September 1, 2017

Annual Report to shareholders and Appendix 4E

August 24, 2017

Business update and earnings guidance

May 19, 2017

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 36 decks. Every deck is listed under its year.